INS and cancer: Insulin may also promote carcinogenesis through indirect mechanisms, via reduction in circulating levels of insulin-like growth factor (IGF)-binding proteins, leading to excess IGF-1 and IGF-2, which further promote cancer cell proliferation [10, 15].